Florian Prueller

740 total citations
13 papers, 562 citations indexed

About

Florian Prueller is a scholar working on Epidemiology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Florian Prueller has authored 13 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Florian Prueller's work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Florian Prueller is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Florian Prueller collaborates with scholars based in Austria, United States and Germany. Florian Prueller's co-authors include Martin Hoenigl, Robert Krause, Reinhard B. Raggam, Juergen Prattes, Albert Wölfler, Jasmin Wagner, Wiebke Duettmann, Birgit Spieß, Dieter Buchheidt and Ines Zollner‐Schwetz and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Florian Prueller

13 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Florian Prueller Austria 12 367 361 70 63 55 13 562
A. Benouda Morocco 11 316 0.9× 146 0.4× 47 0.7× 22 0.3× 22 0.4× 18 753
Handan Akbulut Türkiye 13 149 0.4× 207 0.6× 51 0.7× 81 1.3× 41 0.7× 31 572
João Gouveia Portugal 11 159 0.4× 233 0.6× 42 0.6× 25 0.4× 24 0.4× 25 425
Alexandra Lekkou Greece 11 88 0.2× 461 1.3× 59 0.8× 9 0.1× 41 0.7× 32 719
Nobumasa Aoki Japan 10 96 0.3× 200 0.6× 57 0.8× 27 0.4× 12 0.2× 25 443
Oleg Epelbaum United States 11 305 0.8× 239 0.7× 168 2.4× 28 0.4× 15 0.3× 70 540
Gabriel Morduchowicz Israel 14 128 0.3× 82 0.2× 65 0.9× 22 0.3× 87 1.6× 24 557
Tatsuya Aikawa Japan 15 338 0.9× 358 1.0× 27 0.4× 64 1.0× 45 0.8× 51 974
Veli-Jukka Anttila Finland 11 360 1.0× 309 0.9× 49 0.7× 12 0.2× 27 0.5× 13 536
C. Godet France 17 543 1.5× 544 1.5× 210 3.0× 84 1.3× 8 0.1× 51 837

Countries citing papers authored by Florian Prueller

Since Specialization
Citations

This map shows the geographic impact of Florian Prueller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Prueller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Prueller more than expected).

Fields of papers citing papers by Florian Prueller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Prueller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Prueller. The network helps show where Florian Prueller may publish in the future.

Co-authorship network of co-authors of Florian Prueller

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Prueller. A scholar is included among the top collaborators of Florian Prueller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Prueller. Florian Prueller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Prueller, Florian, et al.. (2022). Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients. Antioxidants. 11(7). 1235–1235. 12 indexed citations
2.
Mahla, Elisabeth, Helfried Metzler, Helmar Bornemann‐Cimenti, et al.. (2018). Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery—The BIANCA Observational Study. Thrombosis and Haemostasis. 118(5). 864–872. 11 indexed citations
3.
Mahla, Elisabeth, Florian Prueller, Gudrun Pregartner, et al.. (2016). Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?. The Annals of Thoracic Surgery. 102(6). 2010–2017. 30 indexed citations
4.
Eigl, Susanne, Martin Hoenigl, Birgit Spieß, et al.. (2016). Galactomannan testing andAspergillusPCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Medical Mycology. 55(5). myw102–myw102. 74 indexed citations
5.
Raggam, Reinhard B., Juergen Prattes, Wiebke Duettmann, et al.. (2015). Detection of (1→3)‐β‐D‐glucan in same‐day urine and serum samples obtained from patients with haematological malignancies. Mycoses. 58(7). 394–398. 13 indexed citations
6.
Hoenigl, Martin, Jasmin Wagner, Reinhard B. Raggam, et al.. (2014). Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria. PLoS ONE. 9(8). e104702–e104702. 34 indexed citations
7.
Hoenigl, Martin, Wiebke Duettmann, Reinhard B. Raggam, et al.. (2014). Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies. International Journal of Antimicrobial Agents. 44(2). 140–144. 22 indexed citations
8.
Schneider, Jochen G., Berend Isermann, Marcus E. Kleber, et al.. (2014). Inverse association of the endogenous thrombin potential (ETP) with cardiovascular death: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. International Journal of Cardiology. 176(1). 139–144. 27 indexed citations
9.
Prattes, Juergen, Martin Hoenigl, Jasmin Rabensteiner, et al.. (2014). Serum 1,3‐beta‐d‐glucan for antifungal treatment stratification at the intensive care unit and the influence of surgery. Mycoses. 57(11). 679–686. 35 indexed citations
10.
Hoenigl, Martin, Juergen Prattes, Birgit Spieß, et al.. (2014). Performance of Galactomannan, Beta- d -Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis. Journal of Clinical Microbiology. 52(6). 2039–2045. 172 indexed citations
11.
Hoenigl, Martin, Reinhard B. Raggam, Jasmin Wagner, et al.. (2014). Procalcitonin fails to predict bacteremia in SIRS patients: a cohort study. International Journal of Clinical Practice. 68(10). 1278–1281. 31 indexed citations
12.
Hoenigl, Martin, Wiebke Duettmann, Reinhard B. Raggam, et al.. (2013). Potential Factors for Inadequate Voriconazole Plasma Concentrations in Intensive Care Unit Patients and Patients with Hematological Malignancies. Antimicrobial Agents and Chemotherapy. 57(7). 3262–3267. 67 indexed citations
13.
Amrein, Karin, Alexander Avian, Katharina Schallmoser, et al.. (2011). Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clinica Chimica Acta. 413(7-8). 678–682. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026